Da Silva, Flávia Regina Moraes [UNESP]Dias, Marcos Correa [UNESP]Barbisan, Luis Fernando [UNESP]Rodrigues, Maria Aparecida Marchesan [UNESP]2014-05-272014-05-272013-05-01Nutrition and Cancer, v. 65, n. 4, p. 571-577, 2013.0163-55811532-7914http://hdl.handle.net/11449/75243Zinc has been proposed as a promising chemopreventive candidate against colon cancer. However, few studies on the potential beneficial effects of this trace element on cancer chemoprevention are available. The present study was designed to investigate the potential modifying influence of zinc gluconate (ZnGly) on the initiation step of colon carcinogenesis induced by 1,2-dimethylhydrazine (DMH). Male Wistar rats received orally ZnGly (15 mg elemental zinc/kg, 3 times per wk) 2 wk before and during DMH treatment (3 × 40 mg/kg, once a wk). The animals were euthanized at the end of 4th and 16th wk. Colons were analyzed for aberrant crypt foci (ACF) and tumor development. Blood and colon zinc levels, cell proliferation, and apoptosis indexes in colonic crypts were analyzed 24 h after the last DMH administration. Oral treatment with ZnGly did neither alter the number of ACF nor the indexes of cell proliferation and apoptosis in the colonic mucosa. The incidence and multiplicity of colon tumors induced by DMH and their histopathological patterns were not modified by previous treatment with ZnGly. These findings indicate a lack of chemopreventive action of zinc gluconate supplementation on the initiation step of rat colon carcinogenesis induced by DMH. © 2013 Copyright Taylor and Francis Group, LLC.571-577enggluconate zincaberrant crypt focusanimal experimentanimal modelapoptosiscell proliferationchemoprophylaxiscolon carcinogenesiscolon mucosacontrolled studydiet supplementationhistopathologymalenonhumanratzinc blood levelArtigo10.1080/01635581.2013.775317WOS:000318973200007Acesso restrito2-s2.0-848779406573278528112652257